[Cost of diabetes mellitus in Spain].
González
Paloma
P
Pfizer, SA Madrid. España. paloma.gonzalez@pfizer.com
Faure
Eduardo
E
Del Castillo
Almudena
A
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D003627:Data Interpretation, Statistical; D048909:Diabetes Complications / Q000188:drug therapy / Q000191:economics* / Q000628:therapy; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000191:economics* / Q000453:epidemiology / Q000628:therapy; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy / Q000191:economics / Q000453:epidemiology / Q000628:therapy; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000191:economics / Q000453:epidemiology / Q000628:therapy; D016527:Drug Costs; D017850:Economics, Pharmaceutical; D017048:Health Care Costs; D006760:Hospitalization / Q000191:economics; D006801:Humans; D007004:Hypoglycemic Agents / Q000191:economics* / Q000627:therapeutic use; D015994:Incidence; D008875:Middle Aged; D015995:Prevalence; D011446:Prospective Studies; D013030:Spain / Q000453:epidemiology
D007004:Hypoglycemic Agents